Pharmaceuticals
-
Malaria vaccination given green light
The world’s first vaccination programme against malaria is to be launched following the success of trials, it has been announced. Read more
-
Novel ventilator could widen access in poorer countries
Scientists have developed a cheaper form of mechanical ventilator to treat patients with respiratory diseases including COVID-19. Read more
-
Hospitalisation risk remains low with mRNA COVID vaccine
Two doses of the Pfizer-BioNTech vaccine for COVID-19 are 90% effective against hospitalisation due to all variants for at least six months, according to the latest analysis. Read more
-
Constipation drug can improve memory and cognition
A drug that treats constipation could also be a useful treatment for cognitive problems in patients with mental illness, according to a new study. Read more
-
New medicines added to essentials lists
Two new lists of essential medicines have been published by the World Health Organization with a pledge it will help widen access to treatments. Read more
-
Taking long-term antidepressants reduces relapse risk
Many users of antidepressants experience a relapse within a year if they stop taking the medication, a new study reveals. Read more
-
Lack of evidence for HRT-dementia risk
There is no strong link between hormone replacement therapy and dementia, according to the findings of a major UK study published today. Read more
-
AI identifies possible drug combination for brain cancer
Artificial intelligence-enhanced tools have been used to identify a new combination of drugs that could treat a rare and incurable childhood brain cancer. Read more
-
Metformin could be a treatment for women with pre-eclampsia
Metformin shows promise as a treatment for preterm pre-eclampsia, a study reveals today. Read more
-
First multi-variant COVID-19 vaccine trial starts
The world’s first multi-variant COVID-19 booster vaccine is to undergo phase 1 trials among older adults in Manchester. Read more
